129
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Synaptic potentiation onto habenula neurons in learned helplessness model of depression

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The cellular basis of depressive disorders is poorly understood 1. Recent studies in monkeys indicate that neurons in the lateral habenula (LHb), a nucleus that mediates communication between forebrain and midbrain structures, can increase their activity when an animal fails to receive an expected positive reward or receives a stimulus that predicts aversive conditions (i.e. disappointment or anticipation of a negative outcome) 2, 3, 4. LHb neurons project to and modulate dopamine-rich regions such as the ventral-tegmental area (VTA) 2, 5 that control reward-seeking behavior 6 and participate in depressive disorders 7. Here we show in two learned helplessness models of depression that excitatory synapses onto LHb neurons projecting to the VTA are potentiated. Synaptic potentiation correlates with an animal’s helplessness behavior and is due to an enhanced presynaptic release probability. Depleting transmitter release by repeated electrical stimulation of LHb afferents, using a protocol that can be effective on depressed patients 8, 9, dramatically suppresses synaptic drive onto VTA-projecting LHb neurons in brain slices and can significantly reduce learned helplessness behavior in rats. Our results indicate that increased presynaptic action onto LHb neurons contributes to the rodent learned helplessness model of depression.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          Short-term synaptic plasticity.

          Synaptic transmission is a dynamic process. Postsynaptic responses wax and wane as presynaptic activity evolves. This prominent characteristic of chemical synaptic transmission is a crucial determinant of the response properties of synapses and, in turn, of the stimulus properties selected by neural networks and of the patterns of activity generated by those networks. This review focuses on synaptic changes that result from prior activity in the synapse under study, and is restricted to short-term effects that last for at most a few minutes. Forms of synaptic enhancement, such as facilitation, augmentation, and post-tetanic potentiation, are usually attributed to effects of a residual elevation in presynaptic [Ca(2+)]i, acting on one or more molecular targets that appear to be distinct from the secretory trigger responsible for fast exocytosis and phasic release of transmitter to single action potentials. We discuss the evidence for this hypothesis, and the origins of the different kinetic phases of synaptic enhancement, as well as the interpretation of statistical changes in transmitter release and roles played by other factors such as alterations in presynaptic Ca(2+) influx or postsynaptic levels of [Ca(2+)]i. Synaptic depression dominates enhancement at many synapses. Depression is usually attributed to depletion of some pool of readily releasable vesicles, and various forms of the depletion model are discussed. Depression can also arise from feedback activation of presynaptic receptors and from postsynaptic processes such as receptor desensitization. In addition, glial-neuronal interactions can contribute to short-term synaptic plasticity. Finally, we summarize the recent literature on putative molecular players in synaptic plasticity and the effects of genetic manipulations and other modulatory influences.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Depression: a new animal model sensitive to antidepressant treatments.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              New approaches to antidepressant drug discovery: beyond monoamines.

              All available antidepressant medications are based on serendipitous discoveries of the clinical efficacy of two classes of antidepressants more than 50 years ago. These tricyclic and monoamine oxidase inhibitor antidepressants were subsequently found to promote serotonin or noradrenaline function in the brain. Newer agents are more specific but have the same core mechanisms of action in promoting these monoamine neurotransmitters. This is unfortunate, because only approximately 50% of individuals with depression show full remission in response to these mechanisms. This review summarizes the obstacles that have hindered the development of non-monoamine-based antidepressants, and provides a progress report on some of the most promising current strategies.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                0028-0836
                1476-4687
                17 December 2010
                24 February 2011
                23 February 2012
                : 470
                : 7335
                : 535-539
                Affiliations
                [1 ]Center for Neural Circuits and Behavior, Departments of Neuroscience and Biological Sciences, University of California at San Diego, La Jolla CA 92093
                [2 ]Cold Spring Harbor Laboratory, Cold Spring Harbor NY 11724
                [3 ]Brookhaven National Laboratory, Upton, NY 11973
                Author notes
                [# ]Correspondence: Roberto Malinow, MD PhD, 9500 Gilman Drive # 0634, La Jolla CA 92093, rmalinow@ 123456ucsd.edu , Bo Li, PhD, 1 Bungtown Road, Cold Spring Harbor NY 11724, bli@ 123456cshl.edu
                [*]

                these authors contributed equally to this work

                Article
                nihpa257146
                10.1038/nature09742
                3285101
                21350486
                c888c787-7a85-4a56-9e57-4aebb3b83d3b

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Aging : NIA
                Award ID: R01 MH091903-01 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Aging : NIA
                Award ID: R01 MH049159-09 ||MH
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Aging : NIA
                Award ID: R01 AG032132-15 ||AG
                Funded by: National Institute of Mental Health : NIMH
                Funded by: National Institute on Aging : NIA
                Award ID: R01 AG032132-14 ||AG
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article